A phase I, placebo controlled, dose escalation safety andpharmacokinetic study of Topical Endoxifen in healthy male volunteers.
Phase of Trial: Phase I
Latest Information Update: 18 Apr 2018
At a glance
- Drugs Endoxifen (Primary)
- Indications Breast cancer; Gynaecomastia
- Focus Adverse reactions
- Sponsors Atossa Genetics
- 12 Apr 2018 According to an Atossa Genetics media release, first of three cohorts has been fully enrolled, and other two cohorts are expected to enroll this quarter.
- 28 Mar 2018 New trial record
- 22 Mar 2018 According to a Atossa Genetics media release, Started enrolling in volunteers.